Sheng Teng

No.19 Yuquan Road
Yuquan, 100049, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Evaluation of the efficacy and safety of immunotherapy in sarcoma: a two-center study.

Evaluation of the efficacy and safety of immunotherapy in sarcoma: a two-center study.

Journal: Frontiers in immunology

Published: September 11, 2023

Clinicopathologic features, prognostic factors, and outcomes of visceral sarcomas: A retrospective 12-year single-center study.

Clinicopathologic features, prognostic factors, and outcomes of visceral sarcomas: A retrospective 12-year single-center study.

Journal: Frontiers in oncology

Published: August 28, 2022

The efficacies and biomarker investigations of antiprogrammed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma.

The efficacies and biomarker investigations of antiprogrammed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma.

Journal: Cancer biology & medicine

Published: November 24, 2021

Chemotherapy Combined With Recombinant Human Endostatin (Endostar) Significantly Improves the Progression-Free Survival of Stage IV Soft Tissue Sarcomas.

Chemotherapy Combined With Recombinant Human Endostatin (Endostar) Significantly Improves the Progression-Free Survival of Stage IV Soft Tissue Sarcomas.

Journal: Frontiers in oncology

Published: September 21, 2021

A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma.

A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma.

Journal: Nature communications

Published: July 09, 2021

Clinical study of apatinib in the treatment of stage IV osteogenic sarcoma after failure of chemotherapy.

Clinical study of apatinib in the treatment of stage IV osteogenic sarcoma after failure of chemotherapy.

Journal: Cancer biology & medicine

Published: November 06, 2019

Efficacy and safety of the VEGFR2 inhibitor Apatinib for metastatic soft tissue sarcoma: Chinese cohort data from NCT03121846.

Efficacy and safety of the VEGFR2 inhibitor Apatinib for metastatic soft tissue sarcoma: Chinese cohort data from NCT03121846.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 29, 2019

Genome-wide binding analysis reveals that ANAC060 directly represses sugar-induced transcription of ABI5 in Arabidopsis.

Genome-wide binding analysis reveals that ANAC060 directly represses sugar-induced transcription of ABI5 in Arabidopsis.

Journal: The Plant journal : for cell and molecular biology

Published: January 10, 2019

Outcomes of surgery and/or combination chemotherapy for extraskeletal osteosarcoma: a single-center retrospective study from China.

Outcomes of surgery and/or combination chemotherapy for extraskeletal osteosarcoma: a single-center retrospective study from China.

Journal: Scientific reports

Published: November 14, 2018

Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety.

Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety.

Journal: Experimental & molecular medicine

Published: September 20, 2018

Apatinib as targeted therapy for sarcoma.

Apatinib as targeted therapy for sarcoma.

Journal: Oncotarget

Published: December 13, 2017

Rice TSV3 Encoding Obg-Like GTPase Protein Is Essential for Chloroplast Development During the Early Leaf Stage Under Cold Stress.

Rice TSV3 Encoding Obg-Like GTPase Protein Is Essential for Chloroplast Development During the Early Leaf Stage Under Cold Stress.

Journal: G3 (Bethesda, Md.)

Published: November 23, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026